KALV today

$27.00+$0.01 (+0.04%)close Jun 10, 2026

Trend

—

Key levels

Resistance$28.15

Resistance$27.53

Support$26.84

Support$26.66

Latest news & SEC filings

No headlines in the last 90 days.

Nasdaq · Healthcare

KalVista Pharmaceuticals, Inc. (KALV)

$27.00+0.01 (+0.04%)
HOLDGrade: CRisk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
26.7226.7926.8626.9327.00May 7May 15May 26Jun 3
High27.00
Low26.98
Open26.98
Volume3.91M
Avg Vol4.68M
VWAP27.00
30d High27.00
30d Low26.65
30d Chg+1.24%
See full chart with real-time data

What Is the Price Target for KALV?

SEPT Low Target

$23.80

SEPT Mid Target

$28.00

SEPT High Target

$32.20

Analyst Consensus

$28.00

Current: $26.99Upside: +3.7%Confidence: 65%Method: Analyst Consensus

Is KALV a Buy or Sell Right Now?

41
Investability Score
HOLD12-18 months

Thesis

    AI-Powered Trading Signals

    Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for KALV.

    Start Free Trial →

    Is KALV Overvalued or Undervalued?

    Valuation Verdict

    N/A

    Methods Used

    N/A

    Fair Value

    $28.00

    5

    Moat Score

    NONE

    1/9

    Piotroski Score

    N/A

    Altman Z-Score

    What Is Smart Money Doing with KALV?

    Insider Signal

    SELLING

    0 buys / 9 sells (90d)

    Congress Signal

    NEUTRAL

    0 buys / 0 sells (90d)

    Institutional

    NEUTRAL

    Short Squeeze Risk

    LOW

    Signal: NEUTRAL

    Recent Insider Activity

    NameTitleTypeSharesValueDate
    Audhya Paul K.officerSale150,260-Jun 11, 2026
    Sweeny NicoleofficerSale59,291-Jun 11, 2026
    Piekos BrianofficerSale21,661-Jun 11, 2026
    Yea ChristopherofficerSale229,918-Jun 11, 2026
    Palleiko Benjamin Ldirector officerSale479,989-Jun 11, 2026
    Yea ChristopherofficerBuy33,800$239KMay 27, 2026
    Yea ChristopherofficerSale33,800$905KMay 27, 2026
    Audhya Paul K.officerSale2,239$60KMay 26, 2026
    Sweeny NicoleofficerSale1,489$40KMay 26, 2026
    Yea ChristopherofficerSale1,966$53KMay 26, 2026

    Track Smart Money Across 4,000+ Stocks

    Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

    See All Smart Money Signals →

    KALV Growth Story

    Revenue YoY

    N/A%

    3yr Revenue CAGR

    N/A%

    EPS Growth YoY

    N/A

    FCF Growth YoY

    -71.8%

    Revenue Trend

    UNKNOWN

    Full AI Research Report

    SEPT's Trading AI has generated a free, downloadable PDF research report for KalVista Pharmaceuticals, Inc. (KALV) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

    Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...

    Sign Up Free — Download AI Report PDF →

    AI-Powered Trading Signals.

    Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

    Try SEPT Free for 7 Days →

    Compare SEPT with other platforms

    SEPT vs TradingViewSEPT vs BloombergSEPT vs Unusual WhalesSEPT vs SpotGammaSEPT vs TrendSpiderAI Trading Platforms Compared
    What is dark pool trading?How to read options flowGEX explainedSmart money trackingAI stock analysisEarn money on SEPT

    About SEPT Investing

    SEPT Investing tracks 13,000+ stocks with live charts, trend and key-level tracking, dark pool and options flow, insider and congress trades, SEC filings and news alerts.

    Disclaimer: This page is for informational purposes only. It does not constitute financial advice. Past performance does not guarantee future results. Always do your own research before making investment decisions.

    KALV — frequently asked questions

    What is KALV stock price today?

    KalVista Pharmaceuticals, Inc. (KALV) is at $27.00, up 0.04% (+$0.01) at the Jun 10, 2026 close.

    What is the KALV price target?

    The average analyst price target for KALV is $28.00, ranging from $27 to $42, based on 3 analysts. Latest: HC Wainwright & Co. downgrade on May 1, 2026.

    What do analysts rate KALV?

    Analyst ratings for KALV: 0 Buy, 2 Hold, 2 Sell — consensus Hold.

    What are KALV support and resistance levels?

    Support: $26.84, $26.66, $26.50. Resistance: $27.53, $28.15, $28.65.

    What are insiders doing with KALV?

    Insider activity: SELLING, 0 buys and 9 sells in the last 90 days.